Literature DB >> 16377499

Assessment of obesity-related comorbidities: a novel scheme for evaluating bariatric surgical patients.

Mohamed R Ali1, Mary Beth Maguire, Bruce M Wolfe.   

Abstract

BACKGROUND: Bariatric surgery serves as the superior means of achieving sustained weight loss and improvement in obesity-related comorbidities. Results of bariatric surgery have been reported qualitatively without standardized measurement of comorbidity response. The objective of this work was to develop a clinically based, standardized system for scaled assessment of the major comorbidities of obesity in patients undergoing bariatric surgery. STUDY
DESIGN: We constructed a standardized grading scheme for the major comorbidities of obesity, with each condition scored from 0 to 5, according to severity. Data were prospectively collected on 226 patients. Ninety patients have already undergone gastric bypass and are being followed at regular intervals postoperatively. Longest current followup interval is 1 year.
RESULTS: Preoperative evaluation of comorbidities identified a total of 1,356 medical disorders. Anatomic comorbidities were most prevalent as a category, although psychosocial impairment was the most common single condition. The majority of comorbidities in our patient population were graded mild (score of 1) to moderate (score of 3). Immediate (2 weeks) followup was available for all operated patients and ranged in number to 1 year postoperatively, depending on the date of operation. Statistically significant reduction in the severity of several comorbidities was observed at postoperative evaluation (p < 0.05).
CONCLUSIONS: This scheme for assessment of obesity-related comorbidities facilitates evaluation of bariatric surgical patients. The system allows standardized preoperative characterization of a bariatric patient population and uniform postoperative longitudinal assessment of changes in comorbidities after weight reduction operation.

Entities:  

Mesh:

Year:  2005        PMID: 16377499     DOI: 10.1016/j.jamcollsurg.2005.09.014

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  16 in total

1.  Changes in renal function following Roux-en-Y gastric bypass: a prospective study.

Authors:  Jorge L Zelada Getty; Isam N Hamdallah; Hazem N Shamseddeen; Jennifer Wu; Roger K Low; Jacqueline Craig; Mohamed R Ali
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

2.  Recognition of comorbid diabetes and obesity in hospital records of newly diagnosed cancer patients.

Authors:  A P Polednak
Journal:  Ann Oncol       Date:  2009-01-23       Impact factor: 32.976

3.  Respiratory events with sugammadex vs. neostigmine following laparoscopic sleeve gastrectomy: a prospective pilot study assessing neuromuscular reversal strategies.

Authors:  Shmuel Evron; Yuri Abelansky; Tiberiu Ezri; Alexander Izakson
Journal:  Rom J Anaesth Intensive Care       Date:  2017-10

4.  First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass.

Authors:  Matthew M Hutter; Bruce D Schirmer; Daniel B Jones; Clifford Y Ko; Mark E Cohen; Ryan P Merkow; Ninh T Nguyen
Journal:  Ann Surg       Date:  2011-09       Impact factor: 12.969

5.  Following Bariatric Surgery: an Exploration of the Couples' Experience.

Authors:  Mary Lisa Pories; Jennifer Hodgson; Mary Ann Rose; John Pender; Natalia Sira; Melvin Swanson
Journal:  Obes Surg       Date:  2016-01       Impact factor: 4.129

6.  Resolution of systemic hypertension after laparoscopic gastric bypass.

Authors:  Marcelo W Hinojosa; J Esteban Varela; Brian R Smith; Fredrick Che; Ninh T Nguyen
Journal:  J Gastrointest Surg       Date:  2008-12-03       Impact factor: 3.452

7.  The safety and efficacy of bariatric surgery for obese, wheelchair bound patients.

Authors:  G J Williams; P A Georgiou; D M Cocker; G Bonanomi; J Smellie; E Efthimiou
Journal:  Ann R Coll Surg Engl       Date:  2014-07       Impact factor: 1.891

8.  Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > or = 50 kg/m2) compared with gastric bypass.

Authors:  Vivek N Prachand; Marc Ward; John C Alverdy
Journal:  J Gastrointest Surg       Date:  2010-02       Impact factor: 3.452

9.  The application of comorbidity indices to predict early postoperative outcomes after laparoscopic Roux-en-Y gastric bypass: a nationwide comparative analysis of over 70,000 cases.

Authors:  Jin Hee Shin; Mathias Worni; Anthony W Castleberry; Ricardo Pietrobon; Philip A Omotosho; Mina Silberberg; Truls Østbye
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

10.  Risk factors associated with mortality after Roux-en-Y gastric bypass surgery.

Authors:  Peter Benotti; G Craig Wood; Deborah A Winegar; Anthony T Petrick; Christopher D Still; George Argyropoulos; Glenn S Gerhard
Journal:  Ann Surg       Date:  2014-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.